APA (7th ed.) Citation

OH, M., A, R., RA, E., AM, E., M, E., A, B., . . . MA, Y. (2024). Management strategies and outcomes of thromboembolism prevention in atrial fibrillation co-existing with immune thrombocytopenia: A review of evidence. International journal of cardiology. Heart & vasculature, 54, 101493. https://doi.org/10.1016/j.ijcha.2024.101493

Chicago Style (17th ed.) Citation

OH, Metwally, et al. "Management Strategies and Outcomes of Thromboembolism Prevention in Atrial Fibrillation Co-existing with Immune Thrombocytopenia: A Review of Evidence." International Journal of Cardiology. Heart & Vasculature 54 (2024): 101493. https://doi.org/10.1016/j.ijcha.2024.101493.

MLA (9th ed.) Citation

OH, Metwally, et al. "Management Strategies and Outcomes of Thromboembolism Prevention in Atrial Fibrillation Co-existing with Immune Thrombocytopenia: A Review of Evidence." International Journal of Cardiology. Heart & Vasculature, vol. 54, 2024, p. 101493, https://doi.org/10.1016/j.ijcha.2024.101493.